MedTrace Logo

Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D

NCT01571063 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2016-10-25

No results posted yet for this study

Summary

Test the efficacy of vitamin D to improve non-alcoholic steatohepatitis with regard to biochemical and histological parameters.

* Trial with medicinal product

Conditions

  • Non-alcoholic Steatohepatitis (NASH)

Interventions

DRUG

Vitamin D3

Vitamin D3, 2.100 IU/d p.o.

DRUG

Placebo

Placebo Tbl. p.o.

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Andreas Geier, Prof. MD · University Hospital Zurich, Division of Hepatology

  • Beat Muellhaupt, Professor, MD · University Hospital Zurich, Division of Gastroenterology and Hepatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571063 on ClinicalTrials.gov